• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Omicron - COVID-19 Variant (B.1.1529) a "Variant of Concern" & BA.2 sub-variant, XE

https://nypost.com/2021/11/30/regen...cktail-may-be-less-effective-against-omicron/
Regeneron warns its antibody cocktail may be less effective against Omicron variant
By Abraham Ziff
November 30, 2021 1:49pm Updated

Regeneron warned its popular antibody cocktail used to treat high-risk cases of COVID-19 may not be as effective against the new Omicron variant.

The New York-based pharmaceutical company said initial analyses indicate that “there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity.”

Regeneron — which markets REGEN-COV, the most widely used monoclonal antibody therapy to treat COVID-19 in the US — cautioned that further studies are needed to determine whether the Omicron variant can evade its therapies.

It also added that “preliminary analyses suggest” that other treatments it is developing could work against Omicron. Regeneron said it anticipates new data on the treatments sometime next month...
 
Translation google

Omicron variant: the "light at the end of the tunnel" that will end the covid epidemic?
The new variant could sign the end of the epidemic.
...
...."Less and less aggressive"
If that is the case, then why are the ICU and 'High Care' admissions in Gauteng SA up 5x in just 2.5 weeks??

To me this article is just more media driven unwarranted optimism. The hospital data from S. Africa strongly argues the opposite !
FFeGyx7XEAE6HeJ?format=jpg&name=medium.jpg
 
November 30, 2021
1:25 PM CST
Last Updated 3 hours ago

Omicron variant could outcompete Delta, South African disease expert says

By Alexander Winning

JOHANNESBURG, Nov 30 (Reuters) - The Omicron coronavirus variant detected in southern Africa could be the most likely candidate to displace the highly contagious Delta variant, the director of South Africa's communicable disease institute said on Tuesday.
...
"We thought what will outcompete Delta? That has always been the question, in terms of transmissibility at least, ... perhaps this particular variant is the variant," Adrian Puren, acting executive director of South Africa's National Institute for Communicable Diseases (NICD), told Reuters in an interview.
...
Puren said it was too early to say whether Omicron was displacing Delta in South Africa, since local scientists have only produced 87 sequences of Omicron so far.
...
Anne von Gottberg, a clinical microbiologist at the NICD, said it looked like infections were rising throughout the country.

On Monday, an NICD presentation a flagged a large number of COVID-19 admissions among infants aged under two years as an area of concern. But von Gottberg cautioned against linking that with Omicron just yet.

"It looks like in fact some of those admissions might have started before the emergence of Omicron. We are also seeing that there was an increase in influenza cases just in the last month or so, and so we need to be really careful to look at the other respiratory infections," she said.

"We are looking at the data very, very carefully, but at the moment I'm not too sure that we can link it definitively to Omicron."
...


https://www.reuters.com/business/he...south-african-disease-expert-says-2021-11-30/
 
Machine translation.

https://www.nu.nl/coronavirus/61706...de-zich-medio-november-al-door-nederland.html
The omikron variant of the coronavirus has already spread within the Netherlands in mid-November. One of the two people in the Netherlands who tested positive for the omikron variant at the GGD on 19 and 23 November had not been on a trip shortly before and must therefore have contracted the virus in the Netherlands. The RIVM reported this to NU.nl on Tuesday afternoon.
 
Thread by Trevor Bedford
From @trvrb

on #OmicronVariant a few vital insights:

- the virus 1st emerged between between Sep 9 & Oct 13
- spreading at a doubling time rate of 4.9 days
- Rt of #Delta is 0.8; Omicron is abt 2.5
- the Ro depends on population vax rate

Following up here with speculative estimates of the rate of spread of Omicron and a stab at how to apportion this rapid rate of spread between intrinsic transmissibility and immune escape.

https://threadreaderapp.com/thread/1466076761427304453.html
 
Louis Rossouw
@lrossouw
R estimates for COVID-19 in South Africa: https://unsupervised.online/static/covid-19/estimating_r_za.html…
Cape Town, South Africaunsupervised.onlineJoined October 2007
1,000 Following
2,062 Followers



Followed by Andrew Lover, Lorenzo Pezzoli, and 4 others you followTweets
Tweets & replies
Media
LikesLouis Rossouw’s Tweets


Louis Rossouw
@lrossouw
·
Dec 2
Comments on a UK specific report but has some good insights for all about thinking and decision making in this pandemic.
Quote Tweet
ZuXkJ7ld_normal.jpg

COVID-19 Actuaries Response Group
@COVID19actuary
· Dec 2
What does the recent House of Commons report on ‘Coronavirus lessons learned to date’ tell us about groupthink and cognitive bias in making crisis decisions? As the world seeks better understanding of a new variant we consider lessons learned in the UK. https://covidactuaries.org/2021/12/01/cognitive-bias-in-crisis-decision-making/…
Show this thread
1
11
Louis Rossouw
@lrossouw
·
Dec 2
Cases are still rising in South Africa. Last night over 8 500 cases were reported. If we break the cases up by specimen received date and allow for some late reporting we probably had just under 6,000 cases on the 30th and the 7-day moving average is at 3,862.

6
14
38
Show this thread
Louis Rossouw
@lrossouw
·
Dec 2
Other provinces have lower case numbers but cases are rising rapidly with R in most provinces above 2 and certainly above 1.5 in all but Northern Cape where R is just touching 1 now.

1
3
11
Louis Rossouw
@lrossouw
·
Dec 2
Details available here: https://unsupervised.online/static/covid-19/estimating_r_za.html
 
Thread


See new TweetsConversation


Mia Malan

@miamalan
[Thread]
@nicd_sa
, Michelle Groome and Waasila Jassat: 1. SA's 7-day moving average of new daily #COVID19 cases has increased from 332 on 16 Nov to 4,814 on 1 Dec (particularly high increase over the last 2 days) 2. This increase is unprecedented (higher than in any other wave)

3:05 AM · Dec 3, 2021·Twitter Web App
46
Retweets
12
Quote Tweets
85
Likes

Tweet your reply

Reply
Mia Malan

@miamalan
·
5h
Replying to
@miamalan
2. The most rapid increase in new #COVID cases has been seen in Gauteng (red line on left graph)

1
5
28
Mia Malan

@miamalan
·
5h
3. Test positivity rates are a good indication of how rapidly a virus is spreading. + rate = nr of tests coming out +. Over the past week SA's test +rate for #COVID19 has increased from 1-2% to Thurday's 22.4%. Increases over the last 3 days have been particularly high.
 
continued from above and snipped in middle of twitter thread -




Mia Malan

@miamalan
·
5h
4. Here you can see how + rates have increased in provinces. +rates in Gauteng (34%) and Limpopo (28%) are the highest.

1
3
22
Mia Malan

@miamalan
·
5h
5. This graph shows the test positivity rate among different age groups. Although more young people tested + initially in Oct/Nov, that is now moving into older age groups.

1
5
25




Mia Malan

@miamalan
·
5h
13. Northwest: There is an increase in #COVID19 cases and hospital admissions in all districts Limpopo: There is a small increase in hospital admissions in Vhembe, Capricorn and Waterberg districts


1
2
19
Mia Malan

@miamalan
·
5h
14. MP: 1. Small increases in #COVID19 hospital admissions in Ehlazeni and Nkangala 2. Increases in new #COVID19 cases across the province

1
3
17
Mia Malan

@miamalan
·
5h
15. EC: Increases in new #COVID19 cases and small increases in #COVID19 hospital admissions FS: No increases in hospital admissions yet

1
3
18
Mia Malan

@miamalan
·
5h
16. Summary: 1. There is early evidence that the #OmicronVariant = more transmissible + poses an increased risk 4 reinfection 2. We don't know what Omicron's impact is on severe disease - cases are mild so far, but = takes time 2 fall very ill, so we need 2 wait for better data.

3
17
47
Dr Michelle Groome

@Dr_Groome
·
2h
Replying to
@miamalan
and
@nicd_sa
Thanks for summarizing our presentation so well and sharing.
 
Christian Lindmeier:
"I have not seen reports of Omicron related deaths yet."


Translation Google

Omicron: no deaths related to the reported variant (WHO) | AFP
3 Dec 2021

The World Health Organization (WHO) spokesman said on Friday that "all information" was not yet known about Omicron but that to his knowledge, no deaths were yet linked to the Covid variant.

https://www.youtube.com/watch?v=4pYYEntEJEg
 
If it follows the progression of other variants this is a little early to expect to see deaths. The first week is the active viral phase then week 2 the virus begins to clear but the immune pathology kicks in, by week 3 most are beginning to get better but some will progress to severe disease, week four onward those that are not going to make it will start to appear in the statistics. Given this typical time scale a month ago there were not enough cases to be picked up by sequencing. In short it is too soon to know where this variant will fit amongst the others in terms of morbidity and mortality.
 
Last edited:
Gauteng hospital data. Hospitalization is now up 6x compared to a couple weeks ago. 604 cases in ICU. Most likely about a third of these will become fatalities.
FFs7bqmVEAEP4P3
 
https://twitter.com/ydeigin/status/1466879569261207552

Yuri Deigin @ydeigin


Hmm. Durban is where the lab is.


3:17 PM · Dec 3, 2021·Twitter for iPhone



Yuri Deigin
@ydeigin
10h
Replying to@ydeigin





github.com
Sequence of traveller from South Africa failed to get assigned to any lineage by pangolin, with a...
This sequence we got this morning is from a return traveller from South Africa. Pangolin failed to assign any lineage to it, neither scorpio. On UShER tree it is close to one sequence from South Af...



Yuri Deigin
@ydeigin




pubmed.ncbi.nlm.nih.gov
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma - PubMed
SARS-CoV-2 variants of concern (VOC) have arisen independently at multiple locations1,2 and may reduce the efficacy of current vaccines that target the spike glycoprotein of SARS-CoV-23. Here, using...

3:18 PM · Dec 3, 2021·Twitter for iPhone




valentin bruttel @VBruttel

Replying to@ydeigin

So to sum this up: 1) SARS2 Omicron genome looks like it was "separated/frozen" between June 2020 and late summer 2021 - This has never before been seen in nature, only in lab leaked pandemics



en.wikipedia.org
1977 Russian flu - Wikipedia

5:57 PM · Dec 3, 2021·Twitter Web App




valentin bruttel

@VBruttel
7h

Replying to@VBruttel
and@ydeigin

2) SARS2 Omicron has 25:1 non-synonymous:synonymous mutations ratio. https://twitter.com/P_J_Buckhaults/s...374038530?s=20

Natural evolution would result in 25:50-100 ratios. The only logical explanation here is targeted manipulation.

ltTZ_Szg_mini.jpg

Dr B.@P_J_Buckhaults

· Nov 30

Omicrons (B.1.1.529) most recent common ancestor is AV.1. Relative to this MRCA, Omicron has 25 nonsynonymous and 1 synonymous mutation in Spike, and 13 nonsynonymous and 6 synonymous mutations in the entire rest of the genome. This is very strange & I don't understand.




valentin bruttel
@VBruttel

Replying to@VBruttel
and@ydeigin

3) No SARS2 Omicron predecessors have been detected between June 2020 and fall 2021, despite their supposedly already higher infectivity. So in this time, - a single isolated patient bred more mutations than >100Mio others? - survived continous infection in complete isolation?

6:19 PM · Dec 3, 2021·Twitter Web App



valentin bruttel
@VBruttel·
7h

Replying to@VBruttel
and@ydeigin


4) Omicron is better adapted to humans and likely also to vaccinated/recovered humans. If this was acquired in a large pool of humans, we would have seen predecessors of this variant before. Evolution in animals should have resulted in a less-well adapted variant.



valentin bruttel

@VBruttel·
7h

5) The only plausible explanation how this huge number of mutations could have been acquired completely below the radar is: - scientists enabled SARS2 samples to escape antibody responses by passaging them in presence of diluted convalescent serum on human/humanized cell lines.
 
Source: https://www.fxempire.com/news/artic...picked-up-a-piece-of-common-cold-virus-830065

Omicron variant may have picked up a piece of common-cold virus
By:Reuters
Updated: Dec 4, 2021, 04:21 EST•2min read

By Nancy Lapid NEW YORK (Reuters) – The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations by picking up a snippet of genetic material from another virus – possibly one that causes the common cold – present in the same infected cells, according to researchers.

This genetic sequence does not appear in any earlier versions of the coronavirus, called SARS-CoV-2, but is ubiquitous in many other viruses including those that cause the common cold, and also in the human genome, researchers said.

By inserting this particular snippet into itself, Omicron might be making itself look “more human,” which would help it evade attack by the human immune system, said Venky Soundararajan of Cambridge, Massachusetts-based data analytics firm nference, who led the study https://osf.io/f7txy posted on Thursday on the website OSF Preprints....
 
Omicron Up Close: South Africa’s Experts Tell Their Stories

By Janice Kew and Michael Cohen
December 3, 2021, 2:11 AM CST
...
Richard Friedland, chief executive officer of Netcare Ltd., which operates the largest private health-care network in South Africa:

“If in the second and third wave we’d seen these levels of positivity to tests conducted, we would have seen very significant increases in hospital admissions and we’re not seeing that. In our primary care clinics it is mainly people under 30-years-old.”

“So I actually think there is a silver lining here and this may signal the end of Covid-19, with it attenuating itself to such an extent that it’s highly contagious, but doesn’t cause severe disease. That’s what happened with Spanish flu.”
...

Shabir Madhi, a vaccinologist from the University of the Witwatersrand, who led trials of both AstraZeneca Plc’s and Novavax Inc.’s shots in South Africa:
...
“I’m optimistic that in this resurgence, while the total number of cases will probably be greater, hospitalizations and deaths will be lower than what we experienced during the course of any of the first three waves.
...

Anne von Gottberg, a clinical microbiologist at South Africa’s National Institute for Communicable Diseases:

“All the data has shown that children have a less severe clinical course and we’ve had some anecdotal reports from hospitals in South Africa, that yes, they are seeing a few more children in some of the hospitals and are admitting them, but many of them have an uncomplicated clinical course during the few days that they are in hospital.”
...
“This virus may be similar to delta in its ability to spread or in being contagious. However, it’s the susceptibility of the population that is greater now because previous infection used to protect against delta and now, with omicron, it doesn’t seem to be the case.”

“However, we believe that with the reinfections the disease will be less severe and the same would hold for those that are vaccinated. So that would be good news.”

...

https://www.bloomberg.com/news/arti...ose-south-africa-s-experts-tell-their-stories
 
Translation Google

Omicron Variant: What if the appearance of this "super variant" was good news?

The new strain could be less dangerous by dint of having mutated. But scientists believe it is still too early to support such a hypothesis.


Audrey Parmentier
Published on 12/04/2021 at 12:59, updated to 22:55

The sentence seems so surprising that it has been repeated in many media: The Omicron variant "could be good news", said virologist Yves Van Laethem in the Belgian daily La DH . While the new strain detected in South Africa worries the whole world which is barricaded , the specialist affirms that it could be "a very beautiful gift from Saint-Nicolas, in the sense that a less virulent variant would replace the other and allow to the unvaccinated to be immunized. If the patients have a cold and 37.7 fever, this is less of a problem. " In other words, he believes that the mutation of a virus can lead to a decrease in its lethality and thus make the disease mild. If the Omicron variant causes milder forms of the disease while being transmitted more quickly, it could therefore reverse the Delta variant - the main source today. For the time being, no death linked to this new mutant has been detected in the world, recalled the WHO on Saturday.

Other specialists abound in this direction: "This new variant is perhaps the light at the end of the tunnel. It is a very contagious variant, but perhaps not as aggressive as is feared", also advanced the November 30, Zvika Granot, professor of immunology at the Hebrew University of Jerusalem. These remarks echo those of the president of the Association of South African Physicians, Angelique Coetzee who said last week that she had received patients with positive Covid tests with unusual symptoms. "What brought them to my practice" in Pretoria, "was extreme fatigue," she said. "I'm not saying that there won't be serious illnesses" but "for now even the patients we have seen who were not vaccinated have mild symptoms," she said. . In the process, Dr Coetzee recalls that very little is known about the dangerousness of this variant that the WHO has however qualified as "worrying".

Between hope and concern, the Omicron variant is at the heart of scientific discussions. Among the questions that flow: Could Sars-CoV-2 turn into a mild disease with this new strain? Asked by L'Express, virologist Hervé Fleury and professor emeritus at the CNRS and the University of Bordeaux, replied that several options are on the table: "You have to be patient and wait a few weeks before being able to respond." In order to obtain a more precise picture of the Omicron variant, the evolution of current patients in the coming days will make it possible to assess the seriousness of the situation. Note that in South Africa- country most affected by the new variant - a peak in infections among children was reported by health authorities on Friday. With 16,000 new cases per day - due to the Omicron variant - South African pathogenicity data is eagerly awaited. "The tragedy is that everyone is making assumptions, but no one yet has solid data," annoys Hervé Fleury.

Omicron "disabled" by dint of having transferred

While conclusions cannot be drawn immediately, the virologist admits that the hypothesis that the Omicron variant could be good news is one of the possibilities to be considered. While the highly transmissible Delta variant contains nine mutations on the Spike protein, which plays an important role in infection, the Omicron variant has 32 mutations in this protein and around 50 in all. According to Hervé Fleury, the new strain could end up "handicapped" by having so much mutated. If it gained in transmissibility - because it had no other choice to maintain itself - it could have lost in virulence by dint of being transformed. "The Omicron variant has so many mutations that it could be less pathogenic. If this is confirmed, it could become a very interesting strain for the human species", underlines the professor emeritus who takes care to use the conditional each time .

Pending the results, the Delta variant continues to kill in France and remains the number one enemy. Until Omicron replaces it, maybe. "It could become a type of benign coronavirus that we already know in winter in our regions and which affects children", continues Professor Fleury before adding that this obviously remains to be proven. Across the Atlantic, the discourse is the same. "What we must do is simply continue to monitor the situation, obtaining as much information and data as possible," said Antony Fauci, White House adviser on the health crisis, on Friday. In France, scientists are divided on the assumptions about Omicron. On Twitter, medical biologist Claude-Alexandre Gustave recalls that "variants have also always been more contagious ... without being less virulent."
...
According to some scientists, the virus needs to produce viral particles in order to be transmitted. "If a variant is more contagious, there is a chance that it will be more virulent", declared Mircea Sofonea, epidemiologist and specialist in the modeling of infectious diseases at the University of Montpellier, in the columns of Le Figaro . For now, there is therefore nothing to confirm that a virus that has become more transmissible would be less dangerous. "Among the other options on the table, the Omicron variant could be more dangerous, more transmissible and escape vaccines", continues Hervé Fleury. Especially since according to a study made available Thursday on the pre-publication site medRxiv,, but which has not yet been peer-reviewed, reinfection of infected subjects is three times more frequent with the Omicron variant compared to waves linked to the Beta and Delta variants. "We must also take this into account. We have hypotheses which are also not very good", concludes the virologist.

https://www.lexpress.fr/actualite/so...e_2163684.html
 
Continued mass vaccination will only push the evolutionary capacity of SARS-CoV-2 Spike protein beyond the Omicron version

Updated 7:41 AM EST, Tue November 30, 2021

By By G. Vanden Bossche, DVM, PhD
...

As the scientifically perverse narrative continues to add fuel to the fire, it is difficult to believe that Omicron will be the end station of the pandemic train that’s out of control. Omicron is likely to start out as a mild disease because short-lived, poorly functional anti-S antibodies (Abs) that resulted from previous asymptomatic infection (e.g., with another previously dominant variant) will no longer recognize Omicron. It is, indeed, highly likely that resistance of Omicron will not be limited to vaccinal Abs but also to naturally induced low affinity Abs that result from asymptomatic/ mild infection. Consequently, Abs from such previous infection would no longer compete with relevant innate Abs for binding to the virus. Individuals who previously contracted asymptomatic/ mild infection will, therefore, be able to fully rely on their first line of immune defense to deal with Omicron. This will leave our ‘experts’ with the impression that the virus (in fact Omicron) is becoming less virulent (than Delta) and is on its way to transit into endemicity. However, the overall pattern of ‘mild’ disease would only prevail until Omicron becomes dominant and causes high infection rates. When this happens, short-lived, low affinity anti-S Abs will start to compete with innate Abs in an increasing part of the population as a direct result of the enhanced likelihood of re-exposure shortly after previous infection. High Omicron infection rates will prevent short-lived, poorly functional anti-S Abs from declining in large parts of the population. This, combined with continued mass vaccination with (inevitable?) anti-Omicron vaccines, will enable large populations to exert immune pressure on Omicron’s infectiousness. None of these immune responses is, however, capable of curtailing viral transmission (it’s now widely acknowledged that the type of C-19 vaccines used by the industry is not capable of blocking transmission)....
 
Back
Top Bottom